MedTrace Logo

The RAPID Trial: Assessing Point-of-care Influenza and Other Respiratory Virus Diagnostics

NCT03756753 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 913

Last updated 2021-11-09

No results posted yet for this study

Summary

The RAPID trial is a randomized controlled trial that looks at the clinical impact of a rapid respiratory test in a pediatric emergency department. Participants will be randomized to the intervention group - results available to medical providers, or the control group- results not available to medical providers.

Conditions

  • Respiratory Pathogens
  • Upper Respiratory Tract Illness
  • Lower Respiratory Tract Illness
  • Acute Respiratory Infection

Interventions

DIAGNOSTIC_TEST

Results available to provider

Results of point of care testing are given to provider

Sponsors & Collaborators

  • Biofire

    collaborator UNKNOWN

  • University of Colorado, Denver

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-03
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03756753 on ClinicalTrials.gov